Pierre-francois F. Laterre

Brussels, BRU, Belgium

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 146 publications

Vancomycin optimised dosing regimens for critically ill patients receiving renal replacement therapy.

Vancomycin optimised dosing regimens for critically ill patients receiving renal replacement therapy.

Journal: Critical care (London, England)

Published: June 22, 2026

Health-related quality of life trajectories one year after COVID-19-induced ARDS: A secondary analysis of the CONFIDENT trial.

Health-related quality of life trajectories one year after COVID-19-induced ARDS: A secondary analysis of the CONFIDENT trial.

Journal: Annals of intensive care

Published: March 06, 2026

Corrigendum to "COVID-19: an 'extraterrestrial' disease?", [International Journal of Infectious Diseases, Volume 110, 155-159, September 2021].

Corrigendum to "COVID-19: an 'extraterrestrial' disease?", [International Journal of Infectious Diseases, Volume 110, 155-159, September 2021].

Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases

Published: June 24, 2025

Meropenem and piperacillin/tazobactam optimised dosing regimens for critically ill patients receiving renal replacement therapy.

Meropenem and piperacillin/tazobactam optimised dosing regimens for critically ill patients receiving renal replacement therapy.

Journal: Intensive care medicine

Published: May 14, 2025

A mechanism-based prognostic enrichment strategy for the development of the TREM-1 inhibitor nangibotide in septic shock.

A mechanism-based prognostic enrichment strategy for the development of the TREM-1 inhibitor nangibotide in septic shock.

Journal: Intensive care medicine

Published: April 21, 2025

Enibarcimab for the treatment of septic shock in patients selected by a combination of the biomarkers bio-ADM and DPP3: A prespecified subgroup analysis of the AdrenOSS-2 trial.

Enibarcimab for the treatment of septic shock in patients selected by a combination of the biomarkers bio-ADM and DPP3: A prespecified subgroup analysis of the AdrenOSS-2 trial.

Journal: Journal of critical care

Published: January 24, 2025

Pathogen-specific host response in critically ill patients with blood stream infections: a nested case-control study.

Pathogen-specific host response in critically ill patients with blood stream infections: a nested case-control study.

Journal: EBioMedicine

Published: December 15, 2024

Cytomegalovirus Blood DNAemia in Patients with Severe SARS-CoV-2 Pneumonia.

Cytomegalovirus Blood DNAemia in Patients with Severe SARS-CoV-2 Pneumonia.

Journal: Infectious disease reports

Published: October 08, 2024

Effect of mesenchymal stem cells on the host response in severe community-acquired pneumonia.

Effect of mesenchymal stem cells on the host response in severe community-acquired pneumonia.

Journal: Thorax

Published: September 25, 2024

Airway epithelium damage in acute respiratory distress syndrome.

Airway epithelium damage in acute respiratory distress syndrome.

Journal: Critical care (London, England)

Published: August 20, 2024

Immunological sub-phenotypes and response to convalescent plasma in COVID-19 induced ARDS: a secondary analysis of the CONFIDENT trial.

Immunological sub-phenotypes and response to convalescent plasma in COVID-19 induced ARDS: a secondary analysis of the CONFIDENT trial.

Journal: Annals of intensive care

Published: May 13, 2024

Convalescent Plasma for Covid-19-Induced ARDS. Reply.

Convalescent Plasma for Covid-19-Induced ARDS. Reply.

Journal: The New England journal of medicine

Published: January 24, 2024

Showing 1-12 of 146

Last Updated: 09/26/2026